Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of DW4902 [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy and safety of DW4902 for uterine fibroids has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Fibroids

Drugs mentioned

• DW4902

Snippet

Sponsor: Daewon Pharmaceutical Co., Ltd. | Conditions: Myoma of Uterus | Phase 2 | Status: COMPLETED